Your physician is the best source for information about your chronic thromboembolic pulmonary hypertension (CTEPH) (WHO Group 4) that is inoperable or recurrent/persistent after surgery. Below you’ll find a list of questions you can ask your doctor to help you better understand your treatment.
Adempas is approved to treat adults with CTEPH (WHO Group 4) that was treated with surgery but who continue to have high pulmonary blood pressure (persistent) or it comes back after surgery (recurrent), or that cannot be treated with surgery (inoperable). The Adempas clinical studies included mostly patients with WHO functional class II-III symptoms. It is not known if Adempas is safe and effective in children.
WHO=World Health Organization